Marit Arnes

748 total citations
22 papers, 560 citations indexed

About

Marit Arnes is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology. According to data from OpenAlex, Marit Arnes has authored 22 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 10 papers in Reproductive Medicine and 9 papers in Immunology. Recurrent topics in Marit Arnes's work include Endometrial and Cervical Cancer Treatments (13 papers), Reproductive System and Pregnancy (9 papers) and Estrogen and related hormone effects (8 papers). Marit Arnes is often cited by papers focused on Endometrial and Cervical Cancer Treatments (13 papers), Reproductive System and Pregnancy (9 papers) and Estrogen and related hormone effects (8 papers). Marit Arnes collaborates with scholars based in Norway, United States and Sweden. Marit Arnes's co-authors include Anne Ørbo, Bjørn Straume, I. Pettersen, Jan Martin Maltau, Turid Kaino, Georg Sager, Margaret Nilsen, Trude Arnesen, Kristin Smistad Myrmel and Emilio Gutiérrez and has published in prestigious journals such as British Journal of Cancer, BJOG An International Journal of Obstetrics & Gynaecology and Gynecologic Oncology.

In The Last Decade

Marit Arnes

21 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marit Arnes Norway 12 411 356 152 120 62 22 560
Haruo Kuroboshi Japan 13 220 0.5× 258 0.7× 215 1.4× 37 0.3× 27 0.4× 22 429
Justyna Sikora Poland 14 293 0.7× 453 1.3× 428 2.8× 31 0.3× 72 1.2× 36 621
I. Pettersen Norway 8 195 0.5× 173 0.5× 79 0.5× 43 0.4× 28 0.5× 9 325
E. Cagnur Ulukus Türkiye 10 241 0.6× 264 0.7× 151 1.0× 26 0.2× 19 0.3× 12 361
B. G. Ward Australia 12 185 0.5× 232 0.7× 63 0.4× 50 0.4× 28 0.5× 19 422
Sachiyo Ueda Japan 7 192 0.5× 307 0.9× 43 0.3× 38 0.3× 29 0.5× 11 393
Jeremiah Shapira Israel 16 423 1.0× 381 1.1× 78 0.5× 314 2.6× 46 0.7× 26 608
Chiharu Yoshimoto Japan 14 300 0.7× 406 1.1× 146 1.0× 16 0.1× 64 1.0× 33 541
Archana Laknaur United States 10 252 0.6× 232 0.7× 58 0.4× 20 0.2× 39 0.6× 24 468
Hirotaka Kajihara Japan 10 214 0.5× 328 0.9× 178 1.2× 14 0.1× 50 0.8× 15 403

Countries citing papers authored by Marit Arnes

Since Specialization
Citations

This map shows the geographic impact of Marit Arnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marit Arnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marit Arnes more than expected).

Fields of papers citing papers by Marit Arnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marit Arnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marit Arnes. The network helps show where Marit Arnes may publish in the future.

Co-authorship network of co-authors of Marit Arnes

This figure shows the co-authorship network connecting the top 25 collaborators of Marit Arnes. A scholar is included among the top collaborators of Marit Arnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marit Arnes. Marit Arnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Arnes, Marit, et al.. (2019). Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study. Anticancer Research. 39(9). 4897–4903. 3 indexed citations
3.
Arnes, Marit, et al.. (2018). Significance of progesterone receptors (PR‐A and PR‐B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 126(7). 936–943. 9 indexed citations
4.
Arnes, Marit, et al.. (2018). Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study. Anticancer Research. 38(5). 2883–2889. 6 indexed citations
5.
Arnes, Marit, et al.. (2017). Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study. Anticancer Research. 37(5). 2529–2536. 8 indexed citations
6.
Ørbo, Anne, et al.. (2016). HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia. British Journal of Cancer. 115(6). 725–730. 12 indexed citations
7.
Ørbo, Anne, et al.. (2016). Relapse Risk of Endometrial Hyperplasia After Treatment With the Levonorgestrel-Impregnated Intrauterine System or Oral Progestogens. Obstetrical & Gynecological Survey. 71(8). 465–466. 3 indexed citations
8.
Ørbo, Anne, et al.. (2015). Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens. BJOG An International Journal of Obstetrics & Gynaecology. 123(9). 1512–1519. 32 indexed citations
9.
Ørbo, Anne, et al.. (2015). Expression of PAX2 and PTEN Correlates to Therapy Response in Endometrial Hyperplasia.. PubMed. 35(12). 6401–9. 12 indexed citations
10.
Arnes, Marit, et al.. (2014). Levonorgestrel-impregnated Intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study.. PubMed. 34(5). 2319–24. 15 indexed citations
11.
Ørbo, Anne, et al.. (2013). Levonorgestrel‐impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial. BJOG An International Journal of Obstetrics & Gynaecology. 121(4). 477–486. 91 indexed citations
12.
Ørbo, Anne, et al.. (2010). Down‐regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system. Acta Obstetricia Et Gynecologica Scandinavica. 89(11). 1438–1446. 25 indexed citations
13.
Ørbo, Anne, et al.. (2010). Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia.. PubMed. 30(11). 4649–55. 4 indexed citations
15.
Ørbo, Anne, et al.. (2008). Treatment results of endometrial hyperplasia after prospective D-score classification. Gynecologic Oncology. 111(1). 68–73. 79 indexed citations
16.
Arnes, Marit, et al.. (2007). Prognosis of Early Cervical Cancer (FIGO Stages IA2, IB, and IIA) in Northern Norway Predicted by Malignancy Grading Score and Objective Morphometric Image Analysis. International Journal of Gynecological Pathology. 26(4). 447–456. 12 indexed citations
18.
Ørbo, Anne, Trude Arnesen, Marit Arnes, & Bjørn Straume. (2004). Resection margins in conization as prognostic marker for relapse in high-grade dysplasia of the uterine cervix in northern Norway: a retrospective long-term follow-up material. Gynecologic Oncology. 93(2). 479–483. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026